Crinetics Pharmaceuticals Ownership | Who Owns Crinetics Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Crinetics Pharmaceuticals Ownership Summary


Crinetics Pharmaceuticals is owned by 113.27% institutional investors, 1.99% insiders. Fmr is the largest institutional shareholder, holding 15.13% of CRNX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.13% of its assets in Crinetics Pharmaceuticals shares.

CRNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCrinetics Pharmaceuticals113.27%1.99%-15.26%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr14.19M15.13%$590.91M
Vanguard group9.17M9.78%$381.94M
Wellington management group llp8.38M8.94%$349.11M
Blackrock6.23M8.62%$279.06M
Blackrock funding, inc. /de7.59M8.09%$315.98M
Driehaus capital management6.48M6.91%$269.96M
Farallon capital management5.77M6.15%$240.32M
Price t rowe associates inc /md/5.31M5.66%$221.01M
Ecor1 capital4.29M4.57%$178.60M
Janus henderson group2.80M3.49%$142.90M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
New leaf venture partners141.00K13.64%$5.87M
Ecor1 capital4.29M8.57%$178.60M
Novo1.63M4.36%$67.68M
First light asset management941.52K3.70%$39.21M
Checkpoint capital260.00K3.63%$10.83M
Ghost tree capital240.00K3.37%$10.75M
Prosight management, lp328.68K3.19%$13.69M
Paradigm biocapital advisors lp2.55M3.02%$106.24M
Siren1.69M2.75%$70.33M
Driehaus capital management6.48M1.93%$269.96M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp8.38M0.06%2.57M
Farallon capital management5.77M0.98%1.12M
Jpmorgan chase1.26M0.00%926.76K
Blackrock6.23M0.01%794.27K
Rtw investments, lp872.39K0.45%405.39K

Top Sellers

HolderShares% AssetsChange
State street2.21M0.00%-1.02M
Vestal point capital, lp750.00K1.41%-750.00K
Lord, abbett---724.63K
T. rowe price investment management60.58K0.00%-655.59K
Franklin resources20.40K0.00%-628.74K

New Positions

HolderShares% AssetsChangeValue
Checkpoint capital260.00K3.63%260.00K$10.83M
Sio capital management174.84K1.84%174.84K$7.28M
Rice hall james & associates174.08K0.40%174.08K$7.25M
Winton group68.20K0.11%68.20K$2.84M
Neuberger berman group67.15K0.00%67.15K$2.80M

Sold Out

HolderChange
Twin peaks wealth advisors-6.00
Corecap advisors-7.00
Capital performance advisors llp-8.00
Cubist systematic strategies-13.00
Northwestern mutual wealth management-16.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20252297.01%106,238,8544.14%1130.96%1270.79%719.23%
Jun 30, 2025219-2.67%104,541,9797.66%1111.02%1293.20%64-11.11%
Mar 31, 2025227-8.84%101,882,1252.21%1090.71%125-15.54%729.09%
Dec 31, 20242432.53%99,207,04017.39%1231.11%14418.03%66-12.00%
Sep 30, 2024235-1.67%84,500,7572.47%1050.81%121-20.91%7437.04%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.95M3.13%-62.07K
Vanguard US Total Market Shares ETF2.40M2.58%2.45K
Vanguard Small Cap Index2.27M2.41%-15.07K
Fidelity OTC2.22M2.36%49.02K
iShares Russell 2000 ETF2.17M2.30%-
US Small-Cap Growth II Equity Comp2.06M2.20%-58.41K
T. Rowe Price New Horizons1.95M2.07%-104.71K
Vanguard Health Care Inv1.32M1.41%-961.79K
T. Rowe Price Integrated US SmCapGrEq1.28M1.38%722.20K
Fidelity Select Health Care1.29M1.37%9.10K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 01, 2025Pizzuti Dana Chief Med and Dev OfficerSell$225.10K
Nov 03, 2025Pizzuti Dana Chief Med and Dev OfficerSell$4.33K
Nov 03, 2025Pizzuti Dana Chief Med and Dev OfficerSell$208.99K
Oct 01, 2025Pizzuti Dana Chief Med and Dev OfficerSell$209.05K
Sep 26, 2025Struthers Richard Scott President & CEOSell$180.00K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3-5
2025 Q2-1
2025 Q1-10
2024 Q4-3

CRNX Ownership FAQ


Who Owns Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals shareholders are primarily institutional investors at 113.27%, followed by 1.99% insiders and -15.26% retail investors. The average institutional ownership in Crinetics Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Crinetics Pharmaceuticals exceeds.

Who owns the most shares of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals’s largest shareholders are Fmr (14.19M shares, 15.13%), Vanguard group (9.17M shares, 9.78%), and Wellington management group llp (8.38M shares, 8.94%). Together, they hold 33.84% of Crinetics Pharmaceuticals’s total shares outstanding.

Does Blackrock own Crinetics Pharmaceuticals?

Yes, BlackRock owns 8.62% of Crinetics Pharmaceuticals, totaling 6.23M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 279.06M$. In the last quarter, BlackRock increased its holdings by 794.27K shares, a 14.61% change.

Who is Crinetics Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Crinetics Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 13.64% of its assets in 141K Crinetics Pharmaceuticals shares, valued at 5.87M$.

Who is the top mutual fund holder of Crinetics Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Crinetics Pharmaceuticals shares, with 3.13% of its total shares outstanding invested in 2.95M Crinetics Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools